Clinical Trials in Bentonville, Arkansas

Find clinical trials in Bentonville, Arkansas. Discover local research opportunities and treatment options in your area.

9 Active Trials Found in Bentonville

Showing 9 trials on this page

Page 1 of 1

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

NCT ID: NCT04777357

This clinical trial is studying a medication called cariprazine to see how well it works for treating depressive episodes in children and teenagers aged 10 to 17 who have bipolar I disorder. Bipola...

Recruiting

Phase: PHASE3 Conditions: Depression, Bipolar I Disorder

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

NCT ID: NCT06951698

This clinical trial is looking to see how effective and safe a new treatment called KarXT is for people experiencing manic episodes due to Bipolar-I Disorder. If you or a loved one has Bipolar-I Di...

Recruiting

Phase: PHASE3 Conditions: Bipolar-I Disorder With Mania or Mania With Mixed Features

Study to Assess the Safety and Effectiveness of NMRA-335140-501

NCT ID: NCT06029439

This clinical trial, named NMRA-335140-501, is studying a new treatment called NMRA-335140 for people with Major Depressive Disorder (MDD). It is an extension of previous studies that looked at how...

Recruiting

Phase: PHASE3 Conditions: Major Depressive Disorder

Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab

NCT ID: NCT06806657

This clinical trial is looking at the safety of a new treatment called garadacimab for people aged 12 and older who have hereditary angioedema (HAE). The study aims to see how well patients do afte...

Recruiting

Phase: PHASE4 Conditions: Hereditary Angioedema

Study of Lumateperone in the Treatment of Patients With Bipolar Mania

NCT ID: NCT06462612

This clinical trial is investigating a medication called Lumateperone to see if it can help treat patients with bipolar I disorder who are experiencing manic episodes. The study is focused on indiv...

Recruiting

Phase: PHASE3 Conditions: Bipolar Disorder, Manic

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

NCT ID: NCT06929273

The BALSAM-3 clinical trial is studying the long-term safety of a medication called KarXT for people with Bipolar-I Disorder who are experiencing manic episodes. This is an important study because ...

Not yet recruiting

Phase: PHASE3 Conditions: Bipolar Disorder Type I With Mania

A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

NCT ID: NCT06894212

This clinical trial is studying a new treatment called SEP-363856 for people who are experiencing severe symptoms of schizophrenia, a mental health condition that can cause delusions, hallucination...

Recruiting

Phase: PHASE3 Conditions: Schizophrenia

A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression

NCT ID: NCT06285916

This clinical trial is studying a new medication called NORA520 to see if it can help women with severe postpartum depression (PPD). Postpartum depression is a type of depression that can occur aft...

Recruiting

Phase: PHASE2 Conditions: Postpartum Depression, Depression, Postpartum +3 more

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

NCT ID: NCT05184335

This clinical trial is studying a medication called Brilaroxazine (RP5063) to see how effective and safe it is for people with schizophrenia, a mental health condition that can affect how a person ...

Recruiting

Phase: PHASE3 Conditions: Schizophrenia

Search All Trials Browse All Locations